v3.26.3
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Cash Flows from Operating Activities:          
Net increase (decrease) in net assets resulting from operations $ 20,327 $ 19,138 $ 60,174 $ 64,080  
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used for) operating activities:          
Net change in unrealized (appreciation) depreciation on investments (10,337) (3,424) (13,358) (8,009)  
Net realized (gain) loss on investments 10,881 930 16,661 (4,832)  
Interest and dividend income paid-in-kind     (9,677) (7,884)  
Accretion of original issue discount     (46) (106)  
Accretion of loan origination fees     (1,960) (2,007)  
Purchase of investments     (268,422) (284,480)  
Proceeds from sales and repayments of investments     164,651 203,319  
Proceeds from loan origination fees     1,729 1,757  
Realized losses on extinguishment of debt 268 304 579 630  
Amortization of deferred financing costs 861 710 2,460 2,024  
Amortization of deferred equity financing costs     17 78  
Changes in operating assets and liabilities:          
Interest receivable     (3,425) (5,370)  
Receivables from investments sold     (11,272)    
Proceeds receivable from stock offering       (681)  
Prepaid expenses and other assets     (494) (308)  
Accrued interest and fees payable     (2,852) (2,081)  
Base management fee payable, net of base management fee waiver - due to affiliate     803 390  
Income incentive fee payable - due to affiliate     306 (106)  
Capital gains incentive fee (reversal) - due to (from) affiliate     (860) 1,972  
Administration fee payable and other - due to (from) affiliate     (104) 10  
Taxes payable     (2,966) (1,104)  
Accounts payable and other liabilities     (643) 526  
Net cash provided by (used for) operating activities     (68,699) (42,182)  
Cash Flows from Financing Activities:          
Proceeds from common stock offerings, net of expenses     35,490 47,780  
Proceeds received from SBA debentures     76,000 44,500  
Repayments of SBA debentures     (24,000) (28,500)  
Proceeds received from issuance of Notes     120,000 100,000  
Principal payments on Notes     (125,000) (25,000)  
Proceeds received from (repayments of) Credit Facilities, net     8,400 (30,000)  
Proceeds received from (repayments of) Secured Borrowings, net     (1,540) (858)  
Payment of deferred financing costs     (4,400) (4,083)  
Dividends paid to stockholders, including expenses     (63,153) (56,492)  
Net cash provided by (used for) financing activities     21,797 47,347  
Net increase (decrease) in cash, cash equivalents and restricted cash     (46,902) 5,165  
Beginning of period     79,606 57,159 $ 57,159
End of period 32,704 $ 62,324 32,704 62,324 79,606
Supplemental cash flow disclosures and Non-cash financing activities:          
Cash payments for interest     32,763 22,248  
Cash payments for taxes, net of tax refunds received     3,556 3,922  
Value of shares issued pursuant to the dividend reinvestment plan       $ 2,012  
Cash and cash equivalents 31,246   31,246   69,995
Restricted cash 1,458   1,458   9,611
Total cash, cash equivalents and restricted cash presented in the Consolidated Statements of Cash Flows $ 32,704   $ 32,704   $ 79,606